On July 14, 2022 Roche reported that it will publish its Half Year Results of 2022 prior to the opening of the Swiss Stock Exchange on Thursday, 21 July 2022 (Press release, Hoffmann-La Roche, JUL 14, 2022, View Source [SID1234616676]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The webinar will start with presentations by senior management, followed by a Q&A session.

Presenters:

Severin Schwan, CEO Roche Group
Bill Anderson, CEO Roche Pharmaceuticals
Thomas Schinecker, CEO Roche Diagnostics
Alan Hippe, Chief Financial and IT Officer
We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*
Should you be unable to register for the webinar due to your company IT policy, please send an email to [email protected].